Web-based survey for dry eye patients (including potential patients)

Web-based survey for dry eye patients (including potential patients) - Web-based survey for dry eye patients (including potential patients)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000057941

Enrollment

1600

Registered

2025-05-26

Start date

2025-05-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye patients and potential dry eye patients

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subjects must meet the following criteria: Dry Eye Patients a) Diagnosed with dry eye by a physician b) Last medical visit within the past 6 months c) Experience of using prescribed eye drops for at least 1 month d) Continuing to use prescribed eye drops Potential Dry Eye Patients 2_1. Those who have discontinued prescribed eye drops a) Diagnosed with dry eye by a physician b) Experience of using prescribed eye drops for at least 1 month c) Currently not using the prescribed eye drops 2_2. Undiagnosed individuals with self-perceived dry eye symptoms a) Have self-perceived dry eye symptoms b) Have not visited an ophthalmologist for dry eye diagnosis

Exclusion criteria

Exclusion criteria: Having no history of either or both of the following diseases: a) Allergic conjunctivitis b) Allergic rhinitis

Design outcomes

Primary

Measure	Time frame
1. Basic information (gender, age, presence of concurrent eye diseases, corrective devices, history of eye-related surgeries) 2. Hospital visits and prescription status (period from symptom awareness to first visit, reason for consultation (or planning to consult), reasons for not seeking or discontinuing treatment, types of prescribed eye drops, usage status) 3. Eye symptoms (measures taken for symptoms, eye symptoms (before treatment, before countermeasures, current), most troublesome symptoms (before treatment, before countermeasures, current)) 4. Desired treatment and tolerance (satisfaction and dissatisfaction with eye drops, desired effects from eye drops, expected time for effects to appear, acceptable number of eye drop applications) 5. Disease awareness (recognition of the need for continued treatment, reasons for this belief, awareness of risks if left untreated)	—

Measure

Time frame

1. Basic information (gender, age, presence of concurrent eye diseases, corrective devices, history of eye-related surgeries) 2. Hospital visits and prescription status (period from symptom awareness to first visit, reason for consultation (or planning to consult), reasons for not seeking or discontinuing treatment, types of prescribed eye drops, usage status) 3. Eye symptoms (measures taken for symptoms, eye symptoms (before treatment, before countermeasures, current), most troublesome symptoms (before treatment, before countermeasures, current)) 4. Desired treatment and tolerance (satisfaction and dissatisfaction with eye drops, desired effects from eye drops, expected time for effects to appear, acceptable number of eye drop applications) 5. Disease awareness (recognition of the need for continued treatment, reasons for this belief, awareness of risks if left untreated)

—

Secondary

Measure	Time frame
Responses to questionnaires targeting potential dry eye patients will be considered as secondary outcomes.	—

Countries

Japan

Contacts

Public ContactYukiko Shibuya

INTAGE Healthcare Inc. Value & Access Department

Yukiko.shibuya@intage.com03-5294-6254

Outcome results